{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:02:27Z","timestamp":1790931747457,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.ijcard.2008.11.211","type":"journal-article","created":{"date-parts":[[2009,2,19]],"date-time":"2009-02-19T09:23:29Z","timestamp":1235035409000},"page":"157-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus \u2013 A pooled meta-analysis of randomized placebo-controlled clinical trials"],"prefix":"10.1016","volume":"141","author":[{"given":"Sandeep A.","family":"Saha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit R.","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2008.11.211_bib1","unstructured":"No authors listed. Complications of Diabetes in the United States. Available on the American Diabetes Association website (URL: http:\/\/www.diabetes.org\/diabetes-statistics\/complications.jsp). Accessed November 26, 2007."},{"key":"10.1016\/j.ijcard.2008.11.211_bib2","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/CIRCULATIONAHA.107.720847","article-title":"Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk","volume":"117","author":"Schramm","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2008.11.211_bib3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1463-1326.2006.00642.x","article-title":"Dyslipidaemia in diabetic patients: time for a rethink","volume":"9","author":"Shepherd","year":"2007","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ijcard.2008.11.211_bib4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1055\/s-2007-980179","article-title":"The clinical relevance of LDL size and subclasses modulation in patients with type-2 diabetes","volume":"115","author":"Rizzo","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.ijcard.2008.11.211_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies","volume":"79","author":"Gordon","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2008.11.211_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0002-9149(02)02436-0","article-title":"The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations","volume":"90","author":"Sacks","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2008.11.211_bib7","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.clinthera.2007.05.002","article-title":"Hypertriglyceridemia and cardiovascular risk reduction","volume":"29","author":"Jacobson","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijcard.2008.11.211_bib8","first-page":"759","article-title":"Results of atromid or CPIB treatment with and without androsterone in hyperlipemia (110 therapeutic trials in 2\u00a0years)","volume":"116","author":"de Gennes","year":"1965","journal-title":"Bull Mem Soc Med Hop Paris"},{"key":"10.1016\/j.ijcard.2008.11.211_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jacc.2004.10.031","article-title":"Efficacy and safety of high-density lipoprotein cholesterol increasing compounds: a meta-analysis of randomized controlled trials","volume":"45","author":"Birjmohun","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"6A","key":"10.1016\/j.ijcard.2008.11.211_bib10","doi-asserted-by":"crossref","first-page":"19C","DOI":"10.1016\/j.amjcard.2006.11.017","article-title":"Expert commentary: the safety of fibrates in lipid-lowering therapy","volume":"99","author":"Brown","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2008.11.211_bib11","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1161\/01.CIR.98.19.2088","article-title":"Mechanism of action of fibrates on lipid and lipoprotein metabolism","volume":"98","author":"Staels","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2008.11.211_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.pa.29.040189.001045","article-title":"Biochemical mechanisms of induction of hepatic peroxisome proliferation","volume":"29","author":"Lock","year":"1989","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.ijcard.2008.11.211_bib13","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.bbalip.2007.04.021","article-title":"PPAR\u03b1 in atherosclerosis and inflammation","volume":"1771","author":"Zandbergen","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ijcard.2008.11.211_bib14","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.bbalip.2007.05.003","article-title":"PPAR\u03b1 and dyslipidemia","volume":"1771","author":"Duval","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ijcard.2008.11.211_bib15","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI27989","article-title":"Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis","volume":"116","author":"Lefebvre","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijcard.2008.11.211_bib16","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1161\/01.ATV.0000204327.96431.9a","article-title":"Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-\u03b1 activators \u2013 clinical and experimental evidence","volume":"26","author":"Zambon","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"10.1016\/j.ijcard.2008.11.211_bib17","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1161\/01.RES.0000127122.22685.0A","article-title":"Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells","volume":"94","author":"Marx","year":"2004","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.ijcard.2008.11.211_bib18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.atherosclerosis.2006.02.036","article-title":"Fenofibrate induces plaque regression in hypercholesterolemic atherosclerotic rabbits: in vivo demonstration by high-resolution MRI","volume":"190","author":"Corti","year":"2007","journal-title":"Atherosclerosis"},{"issue":"50","key":"10.1016\/j.ijcard.2008.11.211_bib19","doi-asserted-by":"crossref","first-page":"48051","DOI":"10.1074\/jbc.M206966200","article-title":"Reduction of atherosclerosis by the peroxisome proliferator-activated receptor alpha agonist fenofibrate in mice","volume":"277","author":"Duez","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijcard.2008.11.211_bib20","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1161\/01.CIR.96.7.2137","article-title":"Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL-C cholesterol","volume":"96","author":"Frick","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2008.11.211_bib21","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(96)91343-4","article-title":"Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients","volume":"347","author":"Ericsson","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2008.11.211_bib22","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0140-6736(00)04209-4","article-title":"Effect of fenofibrate on progression of coronary artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomized study","volume":"357","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ijcard.2008.11.211_bib23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.amjcard.2007.09.095","article-title":"Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen study)","volume":"101","author":"May","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2008.11.211_bib24","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","article-title":"Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement","volume":"354","author":"Moher","year":"1999","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ijcard.2008.11.211_bib25","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0895-4356(98)00131-0","article-title":"The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus","volume":"51","author":"Verhagen","year":"1998","journal-title":"J Clin Epidemiol"},{"issue":"20","key":"10.1016\/j.ijcard.2008.11.211_bib26","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJM198711123172001","article-title":"Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease","volume":"317","author":"Frick","year":"1987","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ijcard.2008.11.211_bib27","doi-asserted-by":"crossref","first-page":"820","DOI":"10.2337\/diacare.15.7.820","article-title":"Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study","volume":"15","author":"Koskinen","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2008.11.211_bib28","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM199908053410604","article-title":"Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol","volume":"341","author":"Rubins","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2008.11.211_bib29","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1001\/archinte.162.22.2597","article-title":"Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans' Affairs High-density lipoprotein Intervention Trial (VA-HIT)","volume":"162","author":"Rubins","year":"2002","journal-title":"Arch Int Med"},{"key":"10.1016\/j.ijcard.2008.11.211_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/01.CIR.102.1.21","article-title":"Secondary prevention by raising HDL-C cholesterol and reducing triglycerides in patients with coronary artery disease \u2013 the Bezafibrate Infarction Prevention (BIP) study","volume":"102","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2008.11.211_bib31","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/archinte.165.10.1154","article-title":"Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome","volume":"165","author":"Tenenbaum","year":"2005","journal-title":"Arch Int Med"},{"key":"10.1016\/j.ijcard.2008.11.211_bib32","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","article-title":"Effects on long-term fenofibrate therapy on cardiovascular events in 9795 in the people with type 2 diabetes mellitus (the FIELD study): randomized controlled trial","volume":"366","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ijcard.2008.11.211_bib33","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2337\/diacare.21.4.641","article-title":"Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study","volume":"21","author":"Elkeles","year":"1998","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.ijcard.2008.11.211_bib34","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijcard.2008.11.211_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ijcard.2008.11.211_bib36","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1136\/bmj.325.7373.1139","article-title":"Bezafibrate in men with lower extremity arterial disease: randomized controlled trial","volume":"325","author":"Meade","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2008.11.211_bib37","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/S0735-1097(98)00442-2","volume":"32","author":"Ruotolo","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ijcard.2008.11.211_bib38","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1185\/030079906X89865","article-title":"Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus: meta-analysis of randomized controlled trials","volume":"22","author":"Allemann","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ijcard.2008.11.211_bib39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis","volume":"371","year":"2008","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1016\/j.ijcard.2008.11.211_bib40","first-page":"S12","article-title":"Standards of Medical Care in Diabetes\u20142008","volume":"31","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2008.11.211_bib41","unstructured":"No authors listed. The Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Available online at http:\/\/www.accordtrial.org\/public\/index.cfm. Accessed April 1, 2008."},{"issue":"3","key":"10.1016\/j.ijcard.2008.11.211_bib42","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jclinepi.2005.08.011","article-title":"A survey identified publication bias in the secondary literature","volume":"59","author":"Carter","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijcard.2008.11.211_bib43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijcard.2008.11.048","article-title":"Ethical authorship and publishing","volume":"131","author":"Coats","year":"2009","journal-title":"Int J Cardiol"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527308013806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527308013806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:25:02Z","timestamp":1759091102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527308013806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0167527308013806"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2008.11.211","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus \u2013 A pooled meta-analysis of randomized placebo-controlled clinical trials","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2008.11.211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}